Literature DB >> 8419095

Propylthiouracil hepatotoxicity. A review and case presentation.

M Levy1.   

Abstract

Propylthiouracil (PTU) is widely used to treat patients with hyperthyroidism. In rare cases, this drug has been found to have severe toxic effects on the liver. The case of a 14-year-old girl treated with PTU for hyperthyroidism who developed jaundice, severe hepatocellular dysfunction, and hepatomegaly is reported. Her condition gradually deteriorated, and she developed paranoid ideation, profound lethargy, and peripheral edema. After three weeks of prednisone therapy, clinical and laboratory signs of improvement were observed. This patient was one of only five pediatric cases among the 16 reported cases of PTU liver toxicity reported to date. Her history and the fatal outcome in some reported cases demonstrate the high degree of sensitivity required to recognize this potential complication in patients treated with PTU, particularly since its immediate discontinuance and steroid-therapy intervention may lead to recovery.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419095     DOI: 10.1177/000992289303200105

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  10 in total

1.  Resolution of propylthiouracil-induced hepatic failure after treatment of thyrotoxicosis.

Authors:  W Khovidhunkit; R V Farese
Journal:  West J Med       Date:  1997-11

2.  Direct effects of propylthiouracil on testosterone secretion in rat testicular interstitial cells.

Authors:  Y C Chiao; H Lin; S W Wang; P S Wang
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

3.  Direct effect of propylthiouracil on progesterone release in rat granulosa cells.

Authors:  Jiann-Jong Chen; Shyi-Wu Wang; Eileen-Jea Chien; Paulus S Wang
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

Review 4.  Graves disease in childhood: a review of the options for diagnosis and treatment.

Authors:  Jorg Dötsch; Wolfgang Rascher; Helmuth G Dörr
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 5.  Liver failure due to antithyroid drugs: report of a case and literature review.

Authors:  Sarantis Livadas; Xenofon Xyrafis; Frangiskos Economou; Georgios Boutzios; Maria Christou; Aristea Zerva; Athanasios Karachalios; Helen Palioura; Sotiria Palimeri; Evanthia Diamanti-Kandarakis
Journal:  Endocrine       Date:  2010-05-18       Impact factor: 3.925

Review 6.  Factors affecting drug-induced liver injury: antithyroid drugs as instances.

Authors:  Reza Heidari; Hossein Niknahad; Akram Jamshidzadeh; Narges Abdoli
Journal:  Clin Mol Hepatol       Date:  2014-09-25

7.  Grave's Disease with Severe Hepatic Dysfunction: A Diagnostic and Therapeutic Challenge.

Authors:  Ashok Krishna Bhuyan; Dipti Sarma; Uma Kaimal Saikia; Bipul Kumar Choudhury
Journal:  Case Rep Med       Date:  2014-09-15

8.  Peripheral blood picture and aminotransferase activity in children with newly diagnosed Graves' disease at baseline and after the initiation of antithyroid drug therapy.

Authors:  Dorota Artemniak-Wojtowicz; Ewelina Witkowska-Sędek; Ada Borowiec; Beata Pyrżak
Journal:  Cent Eur J Immunol       Date:  2019-07-30       Impact factor: 2.085

9.  Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use.

Authors:  Scott A Rivkees; Donald R Mattison
Journal:  Int J Pediatr Endocrinol       Date:  2009-04-21

10.  Carbimazole-Induced Jaundice in Thyrotoxicosis: A Case Report.

Authors:  Abdul Majeed Maliyakkal; Tarik A A Elhadd; Vamanjore A Naushad; Nabeel M Shaath; Khalifa L Farfar; Mustafa S Ahmed; Sahiba M Basheer
Journal:  Cureus       Date:  2021-05-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.